CD229/SLAMF3 Rekombinanter Antikörper

CD229/SLAMF3 Rekombinant Antikörper für WB, IHC, Indirect ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

Maus

Anwendung

WB, IHC, Indirect ELISA

Konjugation

Unkonjugiert

CloneNo.

242312E8

Kat-Nr. : 84817-4-PBS

Synonyme

Lymphocyte antigen 9, Ly-9, Ly9, Cell surface molecule Ly-9, CD229



Geprüfte Anwendungen

Produktinformation

84817-4-PBS bindet in WB, IHC, Indirect ELISA CD229/SLAMF3 und zeigt Reaktivität mit Maus

Getestete Reaktivität Maus
Wirt / Isotyp Kaninchen / IgG
Klonalität Rekombinant
Typ Antikörper
Immunogen Rekombinantes Protein
Vollständiger Name lymphocyte antigen 9
Berechnetes Molekulargewicht73 kDa
Beobachtetes Molekulargewicht80-90 kDa, 110 kDa
GenBank-ZugangsnummerNM_001277968.1
Gene symbol Ly9
Gene ID (NCBI) 17085
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Protein A purfication
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

Signaling lymphocytic activation molecule 3 (SLAMF3), also known as CD229 or Ly9, is a type I transmembrane glycoprotein that belongs to the SLAM family receptors (PMID: 10970093; 15905546). It is composed of an extracellular region, which consists of four Ig-like domains, a transmembrane region, and a cytoplasmic tail, which includes two immunoreceptor tyrosine-based signaling motifs (ITSMs) and other tyrosine residues that act as binding sites for the SH2 structural domains (PMID: 8537117; 11369645; 38626547). SLAMF3 is mainly expressed in immune cells, such as T, B, and natural killer cells, and it is involved in the fundamental activation and suppression of these immune cells, as well as the regulation of complex immune networks (PMID: 38626547).